title: Smad mediated regulation of inhibitor of DNA binding 2 and its role in phenotypic maintenance of human renal proximal tubule epithelial cells.
abstract: The basic-Helix-Loop-Helix family (bHLH) of transcriptional factors plays a major role in regulating cellular proliferation, differentiation and phenotype maintenance. The downregulation of one of the members of bHLH family protein, inhibitor of DNA binding 2 (Id2) has been shown to induce de-differentiation of epithelial cells. Opposing regulators of epithelial/mesenchymal phenotype in renal proximal tubule epithelial cells (PTEC), TGFβ1 and BMP7 also have counter-regulatory effects in models of renal fibrosis. We investigated the regulation of Id2 by these growth factors in human PTECs and its implication in the expression of markers of epithelial versus myofibroblastic phenotype. Cellular Id2 levels were reduced by TGFβ1 treatment; this was prevented by co-incubation with BMP7. BMP7 alone increased cellular levels of Id2. TGFβ1 and BMP7 regulated Id2 through Smad2/3 and Smad1/5 dependent mechanisms respectively. TGFβ1 mediated Id2 suppression was essential for α-SMA induction in PTECs. Although Id2 over-expression prevented α-SMA induction, it did not prevent E-cadherin loss under the influence of TGFβ1. This suggests that the loss of gate keeper function of E-cadherin alone may not necessarily result in complete EMT and further transcriptional re-programming is essential to attain mesenchymal phenotype. Although BMP7 abolished TGFβ1 mediated α-SMA expression by restoring Id2 levels, the loss of Id2 was not sufficient to induce α-SMA expression even in the context of reduced E-cadherin expression. Hence, a reduction in Id2 is critical for TGFβ1-induced α-SMA expression in this model of human PTECs but is not sufficient in it self to induce α-SMA even in the context of reduced E-cadherin.
authors: South West Thames Institute for Renal Research, St.Helier University Hospital NHS Trust, Carshalton, United Kingdom. vmangalakumar1@hotmail.com
authors: Mangalakumar
authors: M
authors: Veerasamy
authors: Mysore
authors: M
authors: Phanish
authors: Mark E C
authors: ME
authors: Dockrell
mesh_terms: D000199:Actins / Q000378:metabolism; D055419:Bone Morphogenetic Protein 7 / Q000378:metabolism; D015820:Cadherins / Q000378:metabolism; D054337:Cell Dedifferentiation; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000378:metabolism; D058750:Epithelial-Mesenchymal Transition; D055785:Gene Knockdown Techniques; D006801:Humans; D051797:Inhibitor of Differentiation Protein 2 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D007687:Kidney Tubules, Proximal / Q000166:cytology* / Q000378:metabolism*; D058628:Myofibroblasts / Q000166:cytology / Q000378:metabolism; D010641:Phenotype; D051785:Smad Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D053773:Transforming Growth Factor beta1 / Q000378:metabolism
chemical_list: C541116:ACTA2 protein, human; D000199:Actins; C525819:BMP7 protein, human; D055419:Bone Morphogenetic Protein 7; D015820:Cadherins; C497450:ID2 protein, human; D051797:Inhibitor of Differentiation Protein 2; D051785:Smad Proteins; D053773:Transforming Growth Factor beta1